These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16401805)

  • 1. Treatment of hepatitis B: who, when, and how?
    Wong SN; Lok AS
    Arch Intern Med; 2006 Jan; 166(1):9-12. PubMed ID: 16401805
    [No Abstract]   [Full Text] [Related]  

  • 2. A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B.
    Lim SG; Ng TM; Kung N; Krastev Z; Volfova M; Husa P; Lee SS; Chan S; Shiffman ML; Washington MK; Rigney A; Anderson J; Mondou E; Snow A; Sorbel J; Guan R; Rousseau F;
    Arch Intern Med; 2006 Jan; 166(1):49-56. PubMed ID: 16401810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing landscape of antiviral resistance management in chronic hepatitis B.
    Nguyen T; Locarnini S; Desmond P
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1314-7. PubMed ID: 18853991
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiviral therapy of chronic hepatitis B.
    Zoulim F
    Antiviral Res; 2006 Sep; 71(2-3):206-15. PubMed ID: 16716414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modern strategy in the treatment of chronic hepatitis B: progress and prospects].
    Isakov VA
    Eksp Klin Gastroenterol; 2007; (2):107-12. PubMed ID: 17539354
    [No Abstract]   [Full Text] [Related]  

  • 6. [Managing resistance to analogue antiviral drugs in a chronic compensated hepatitis B patient].
    Bronowicki JP; Barraud H; Couzigou P
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S17-9. PubMed ID: 17075490
    [No Abstract]   [Full Text] [Related]  

  • 7. HBV Chronic hepatitis during chemotherapy - an immune controlled disease.
    Caruntu FA; Gheorghita V
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):445-9. PubMed ID: 19104707
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic hepatitis B: back to the future with HBsAg.
    Moucari R; Lada O; Marcellin P
    Expert Rev Anti Infect Ther; 2009 Aug; 7(6):633-6. PubMed ID: 19681689
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of children persistently infected with hepatitis B virus: seroconversion or suppression.
    Price N; Boxall EH
    J Antimicrob Chemother; 2007 Dec; 60(6):1189-92. PubMed ID: 17913721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can serum HBV-DNA be used as a primary end point to assess efficacy of new treatments for chronic hepatitis B?
    Alberti A
    Hepatology; 2003 Jul; 38(1):18-20. PubMed ID: 12829981
    [No Abstract]   [Full Text] [Related]  

  • 11. Do guidelines preclude hepatitis B patients from receiving treatment?
    Degertekin B; Lok AS
    Hepatology; 2009 Feb; 49(2):700-1; author reply 701-2. PubMed ID: 19177583
    [No Abstract]   [Full Text] [Related]  

  • 12. [Managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
    Marcellin P; Lada O
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S5-8. PubMed ID: 17075487
    [No Abstract]   [Full Text] [Related]  

  • 13. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection.
    European Association For The Study Of The Liver
    J Hepatol; 2012 Jul; 57(1):167-85. PubMed ID: 22436845
    [No Abstract]   [Full Text] [Related]  

  • 14. [Future perspectives and strategies in managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
    Bourlière M
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S34-6. PubMed ID: 17075495
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis B: the pathway to recovery through treatment.
    Hollinger FB; Lau DT
    Gastroenterol Clin North Am; 2006 Dec; 35(4):895-931. PubMed ID: 17129820
    [No Abstract]   [Full Text] [Related]  

  • 16. Revisiting the treatment recommendations for chronic hepatitis B.
    Chan HL
    Hepatology; 2009 Feb; 49(2):700; author reply 701-2. PubMed ID: 19177582
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic hepatitis B: who to treat and which choice of treatment?
    Di Marco V; Craxì A
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):281-91. PubMed ID: 19344242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chronic hepatitis B or C in HIV-infected patients with dual viral hepatitis.
    Soriano V; Barreiro P; Martín-Carbonero L; Castellares C; Ruiz-Sancho A; Labarga P; Ramos B; Gonzalez-Lahoz J
    J Infect Dis; 2007 Apr; 195(8):1181-3. PubMed ID: 17357055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of chronic hepatitis B. Tenofovir--first choice in current EASL guidelines].
    MMW Fortschr Med; 2009 May; 151(22):38-9. PubMed ID: 19526965
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of hepatitis B in pregnancy: a challenge.
    Kamani L
    J Coll Physicians Surg Pak; 2014 Jan; 24(1):73. PubMed ID: 24411551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.